<DOC>
	<DOCNO>NCT01856634</DOCNO>
	<brief_summary>The purpose trial determine pediatric dose delamanid equivalent adult dose already show effective multidrug-resistant tuberculosis .</brief_summary>
	<brief_title>Pharmacokinetic Safety Trial Determine Appropriate Dose Pediatric Patients With Multidrug Resistant Tuberculosis</brief_title>
	<detailed_description>This trial investigate pharmacokinetics ( PK ) safety delamanid administer 10 day pediatric patient age birth 17 year also therapy optimize background regimen . The purpose trial determine dose pediatric MDR-TB patient result delamanid plasma exposure similar efficacious plasma exposure adult MDR-TB patient . This age de-escalation trial four group : Group 1 : 12 17 year ( 100 mg BID ; n=6 ) Group 2 : 6 11 year ( 50 mg BID ; n=6 ) Group 3 : 3 5 year ( 25 mg BID ; n=12 ) Group 4 : Birth 2 year ( Dose base patient 's body weight , n=12 ) - Patients &gt; 10 kg receive 10 mg BID - Patients &gt; 8 kg ≤ 10 kg receive 5 mg BID - Patient ≤ 8 kg receive 5 mg QD Enrollment complete patient Groups 1 , 2 3 .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Multidrug-Resistant</mesh_term>
	<criteria>Confirmed diagnosis MDRTB OR Presumptive diagnosis MDRTB include one following : Clinical specimen suggestive TB Persistent cough lasting &gt; 2 week Fever , weight loss , failure thrive Findings recent chest radiograph ( prior Visit 1 ) consistent TB AND Household contact person know MDRTB person die appropriately take drug sensitive TB OR On firstline TB treatment clinical improvement Negative urine pregnancy test female patient reach menarche Written inform consent/assent Laboratory evidence active hepatitis B C Children body weight &lt; 5.5 kg For patient HIV coinfection , CD4 cell count ≤ 1000/mm3 child 15 year old , ≤ 1500/mm3 child less 1 year old History allergy metronidazole disease condition metronidazole require Use amiodarone within 12 month use predefined antiarrhythmic medication within 30 day prior first dose delamanid Serious concomitant condition Preexisting cardiac condition Abnormalities Screening ECG ( include AV block , BBB hemiblock , QRS prolongation &gt; 120 msec , QTcF &gt; 450 msec male female ) Concomitant condition renal impairment characterize serum creatinine level &gt; 1.5 mg/dL , hepatic impairment ( ALT AST &gt; 3x ULN ) , hyperbilirubinemia characterize total bilirubin &gt; 2x ULN Current diagnosis severe malnutrition kwashiorkor Positive urine drug screen ( Groups 1 2 ) Rifampicin and/or moxifloxacin within 1 week prior first dose delamanid and/or prior concurrent use bedaquiline Lansky Play Performance Score &lt; 50 ( applicable child &lt; 1 year old ) Karnofsky Score &lt; 50 Administered IMP within 1 month prior Visit 1 Pregnant , breastfeeding , plan conceive father child within timeframe described information consent form ( Groups 1 2 )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Tuberculosis</keyword>
	<keyword>Tuberculosis , Multidrug-Resistant</keyword>
	<keyword>Mycobacterium Infections</keyword>
	<keyword>Actinomycetales Infections</keyword>
	<keyword>Gram-Positive Infections</keyword>
	<keyword>Bacterial Infections</keyword>
	<keyword>Pediatric</keyword>
</DOC>